Skip to main content
Alpa Laboratories Limited logo

Alpa Laboratories Limited — Investor Relations & Filings

Ticker · ALPA ISIN · INE385I01010 LEI · 335800O2RIWENG8KPR59 BSE.NS Manufacturing
Open in API
Filings indexed 321 across all filing types
Latest filing 2022-03-10 Regulatory Filings
Country IN India
Listing BSE.NS ALPA

About Alpa Laboratories Limited

https://alpalabs.in/

Alpa Laboratories Limited specializes in the development and manufacture of a broad range of pharmaceutical formulations for human and veterinary applications. The company's core capabilities include the production of small volume parenterals, such as liquid and dry powder injections, alongside solid orals like tablets and capsules. Its portfolio further extends to topical preparations including ointments, creams, gels, and ophthalmic/otic drops. Utilizing WHO-GMP certified manufacturing units, the organization provides extensive contract manufacturing and research services to prominent global healthcare brands. The company serves diverse therapeutic segments, including anti-infectives, analgesics, and nutritional supplements, maintaining a robust presence in both domestic and international markets through a commitment to stringent quality standards and technical excellence.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2022-03-10 English
General updates
Regulatory Filings
2022-03-07 English
General updates
Major Shareholding Notification Classification · 100% confidence The document is an intimation under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. It details the acquisition of shares among promoters and promoter group members of Alpa Laboratories Limited, including specifics on shareholding percentages before and after the transaction. The document is a formal disclosure of a substantial acquisition of shares as required by SEBI regulations. This fits the definition of a Major Shareholding Notification (MRQ), which involves notification of changes in significant share ownership levels crossing thresholds. There is no indication that this is a full financial report, audit, or other types of filings. The document is about shareholding changes by promoters, so MRQ is the appropriate classification.
2022-03-06 English
General updates
Major Shareholding Notification Classification · 100% confidence The document is an intimation under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. It details the acquisition of shares among promoters and promoter group members of Alpa Laboratories Limited, including shareholding percentages before and after the transaction. The document references SEBI regulations specifically related to substantial acquisition of shares and takeovers. It is a formal disclosure of a change in shareholding by promoters, which fits the definition of a Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report type, nor is it a general regulatory filing or announcement of a report. It is a direct notification of a change in significant share ownership levels, which matches the MRQ category.
2022-03-06 English
General updates
Regulatory Filings
2022-03-06 English
General updates
Major Shareholding Notification Classification · 100% confidence The document is a disclosure submitted to stock exchanges (BSE and NSE) under SEBI regulations, specifically Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, and Form C under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. It details the acquisition of shares by a promoter through gift, including shareholding percentages before and after acquisition, mode of acquisition, and dates. This type of filing is a notification of a substantial acquisition of shares and insider trading disclosure, which fits the category of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding changes.
2022-02-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.